Rtog Foundation, Inc.
Clinical trials sponsored by Rtog Foundation, Inc., explained in plain language.
-
Immunotherapy plus precision radiation shows promise against returning head and neck cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab (Keytruda) to targeted radiation (SBRT) can help people with head and neck cancer that has returned or is a new tumor in the same area. About 86 adults whose cancer cannot be removed by surgery will be randomly …
Phase: PHASE2 • Sponsor: RTOG Foundation, Inc. • Aim: Disease control
Last updated May 17, 2026 13:57 UTC
-
Can a drug combo stop prostate cancer from coming back after surgery?
Disease control OngoingThis study is for men whose prostate cancer has returned after surgery, shown by a rising PSA. It compares standard hormone therapy plus radiation to a stronger version that adds enzalutamide. The goal is to see if the enhanced treatment keeps the cancer from progressing longer. …
Phase: PHASE2 • Sponsor: RTOG Foundation, Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC